4188.TWO AmCad BioMed Corporation

Healthcare Medical Devices Taiwan OTC Exchange
14.70 UYU
Close of Nov 6, 2026
9.06 18.85
Market cap
UYU 931M
P/E
-
P/B
1.93x
ROE
-11.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4188.TWO undervalued?

Graham number

The Graham number of AmCad BioMed Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AmCad BioMed Corporation fundamental analysis

No fundamental analysis for AmCad BioMed Corporation yet.

AmCad BioMed Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AmCad BioMed Corporation

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of b…

Full company profile